Home : FDA Drug Database : Abbokinase : Newsfeeds

Abbokinase - Newsfeeds

Microbix Hires Dr. Andre Uddin of BioStrategy Management: The Company's major pipeline products include: its VIRUSMAX(TM) Technology which significantly boosts the yield of influenza virus from eggs and can help address the current global flu vaccine capacity issue; Urokinase, a thrombolytic biologic that can be ...
Brain stroke treated in time: The block (thrombus) was gradually disintegrated with the help of urokinase, a thrombus bursting agent. It took two hours to disintegrate the block and the blood vessel was totally opened. The patient started improving dramatically and regained power and ...
Dangerous plaques in blood vessels rupture by overproducing protein-busting enzymes: In a mouse study, Dickek and his team transplanted bone marrow containing macrophages that overproduce a protein-digesting enzyme known as urokinase into aged, atherosclerotic mice. These macrophages accumulated in some of the plaques. Compared to ...
China Biotech Week in Review: Deals Abound: of France to develop biological drugs (see story ). The initial product is Urokinase, an enzyme-based formulation used to break up blot clots that is usually sourced from cultured human kidney cells. The JV will be owned 50-50 by the two companies, with ...
Genomic Health Announces Multiple Studies Highlighting Important Role of Oncotype DX(R) in Treating the ...: An additional analysis of preliminary data from the WSG Plan B trial was presented in a separate poster session, and for the first time, compared risk groups using the Oncotype DX Recurrence Score and the invasion markers uPA (urokinase-type plasminogen ...
Seven New Studies Presented at the CTRC-AACR San Antonio Breast Cancer Symposium: SAN ANTONIO , Dec. 13, 2010 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX - News ) today announced results from seven new studies focusing on its multigene Onco type DX ® breast cancer test, which has helped guide treatment decisions in more than ...
Bharat Biotech begins phase III trials of clot-busting drug: Hyderabad, Feb 4 (IANS) Bharat Biotech (www.bharatbiotech.com) Friday announced that it has initiated Phase III clinical trials in India of THR-100 (Staphylokinase), a clot-busting drug for patients suffering an acute myocardial infarction (AMI).The trial ...
Court's Dismissal of Counterclaim Opens Door For Microbix Into U.S. Market for Generic Urokinase: Our two drugs are now poised to fill an unmet medical need caused by the disappearance of Abbott's brands of urokinase (Abbokinase(TM) and OpenCath(TM)) from the market," says William J. Gastle, president and CEO of Microbix. Under Microbix' timetable ...
Can This Merger Be Saved?: In addition to its consent agreement with the FDA, the company's pharmaceutical sales and margins are also under pressure thanks to the FDA forcing the company to take its anti-blood clotting drug Abbokinase off the market earlier this year and recent ...
Abbott Labs: Drugmaker, Heal Thyself: That is likely to cut Hytrin sales to $500 million next year. And early this year, the Food & Drug Administration halted sales of Abbott's $275 million clot-dissolving agent Abbokinase because of poor manufacturing controls. "You've got three blockbusters ...

Is Thrombolytic Therapy Effective for Pulmonary Embolism?: Am Fam Physician. 2002 Mar 15;65(6):1097-1103. Pulmonary embolism is a disorder that is associated with significant morbidity and mortality. Right-sided heart failure and recurrent pulmonary embolism are the main causes of death associated with ...
ImaRx Therapeutics Expands Management Team.: TUCSON, Ariz. -- ImaRx Therapeutics Inc. announced today the appointments of Randall E. Miller, Ph.D., to the position of chief operating officer and Greg A. Cobb to the position of chief financial officer. Miller will advance the company's clinical trials ...
Peripheral Vascular Disease: Diagnosis and Treatment: Am Fam Physician. 2006 Jun 1;73(11):1971-1976. Patient information : A handout on peripheral arterial disease and claudication is available at: http://familydoctor.org/008.xml . Peripheral vascular disease is a manifestation of systemic ...
Neutralisation of uPA with a Monoclonal Antibody Reduces Plasmin Formation and ...: urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA). In contrast, individual genetic deficiencies in either uPA or tPA lead to wound healing kinetics with no or only slightly ...
Scientists fight cancer with viruses: ... epidermal growth factor receptor (EGFR), which is found in higher concentrations on many cancer tumours than on normal cells, and a receptor called the urokinase-type plasminogen receptor (uPAR), which is related to ...
In Vitro Identification of Novel Plasminogen-Binding Receptors of the Pathogen Leptospira ...: Bound PLG could be converted to plasmin by the addition of urokinase-type PLG activator (uPA), showing specific proteolytic activity, as assessed by its reaction with the chromogenic plasmin substrate, D-Val-Leu-Lys 4 ...
AnaSpec Introduces New SensoLyte® uPA & tPA Assay Kits: AnaSpec is pleased to introduce two plasminogen activator assay kits – the SensoLyte AFC Urokinase (uPA) Assay Kit and the SensoLyte AMC tPA Assay Kit. Fremont, CA, June 19, 2010 --( PR.com )-- Plasminogen activator ...
Ideas For Preventive And Therapeutic Approaches Against ...: In a mouse study, Dickek and his team transplanted bone marrow containing macrophages that overproduce a protein-digesting enzyme known as urokinase into aged, atherosclerotic mice. These macrophages accumulated in some of the plaques.
Gentium Announces Fourth Quarter and Year End 2009 ...: ... slightly decreased from EUR 4.79 million in 2008 to EUR 4.6 million , reflecting the decrease in volume of suglicotide offset by a price increase and higher sales volume of urokinase. Sales to a related party, Sirton, for the year ended December ...
Microbix Receives Approval To Market Thrombolytic Agent Kinlytic(TM ...: Approval allows Microbix, the only worldwide source of low-molecular-weight urokinase, to export its clot-busting therapy globally Microbix Biosystems Inc. (MBX:TSX) today announced that KINLYTIC (urokinase for injection) has been approved in Canada ...

Want to contact a Washington, DC Abbokinase lawyer? ...Get a free case evaluation from one of our Washington, DC Abbokinase lawyers now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: 1 2 Next

Need An Abbokinase Attorney?

First Name Last Name Email Address State

Legal Issue

FDA Drug Database: Abbokinase Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Abbokinase Information

Click to View Our Legal Resources

Want to contact a Washington, DC Abbokinase lawyer? ...Get a free case evaluation from one of our Washington, DC Abbokinase lawyers now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120517-102322

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

FDA Drug Database: Abbokinase Click to select a Legal Issue

Close (x)

Find Legal Help for Your Abbokinase Case - Submit Your Information Below

Do you need legal assistance with your Abbokinase case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * FDA Drug Database: Abbokinase Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.